THE LEVEL OF SOLUBLE CD8 MOLECULES IN SERUM AND SPUTUM IN COPD PATIENTS WITH AN EXACERBATION

S. Soodaeva (Moscow, Russian Federation)

Source: International Congress 2017 – Highlights on clinical problems in COPD
Session: Highlights on clinical problems in COPD
Session type: Thematic Poster
Number: 3653
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Soodaeva (Moscow, Russian Federation). THE LEVEL OF SOLUBLE CD8 MOLECULES IN SERUM AND SPUTUM IN COPD PATIENTS WITH AN EXACERBATION. 3653

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


NEBULIZER AEROSOL DRUG DELIVERY THROUGH HIGH FLOW NASAL CANNULA IN ADULT PATIENTS
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


EVALUATION OF THE IMMUNOGLOBULIN G LEVEL AND THE GAMMAGLOBULIN FRACTION OF THE PROTEINOGRAM IN THE COPD EXACERBATOR PHENOTYPE
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019


TWO WEEKS OF INTERMITTENT HYPOXIC EXPOSURE INDUCE LIPOLYSIS AT THE FAT TISSUE LEVEL IN HEALTHY HUMAN SUBJECTS.
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017

EVALUATION OF OF SMALL AIRWAYS INFLAMMATORY PARAMETERS IN A GROUP OF ASTHMATIC PATIENTS
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

ASSOCIATION BETWEEN NEUTROPHIL AND PLATELET TO LYMPHOCYTE RATIO AND DISEASE SEVERITY IN STABLE COPD
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



NEUROMUSCULAR EFFICIENCY DURING EXERCISE IN COPD PATIENTS
Source: International Congress 2019 – Exploring exercise responses in respiratory diseases
Year: 2019


PHYSIOLOGICAL EFFECTS OF THREE DIFFERENT VENTILATORY MODES IN PATIENTS WITH OBESITY HYPOVENTILATION SYNDROME UNDER NOCTURNAL NONINVASIVE VENTILATION: A PILOT RANDOMIZED STUDY
Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure
Year: 2017

COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


COMORBIDITIES AND EXERCISE CAPACITY IN PATIENTS WITH OSTRUCTIVE SLEEP APNOEA
Source: International Congress 2019 – Innovations in care for chronic respiratory conditions
Year: 2019


A COMPARATIVE STUDY ON EFFECTS OF SUBSTANCE DEPENDENCE ON PULMONARY TUBERCULOSIS PATIENTS
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021

THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD.
Source: Eur Respir J 2006; 27: 1076
Year: 2006


IS IRON DEFICIENCY MODULATING PHYSICAL ACTIVITY IN COPD?
Source: International Congress 2017 – Best abstracts in physical activity and management of COPD
Year: 2017

“A RANDOMISED CONTROLLED STUDY ON EFFECT OF ORAL MAGNESIUM SUPPLEMENTS IN CONTROL OF SYMPTOMS OF BRONCHIAL ASTHMA AND LUNG FUNCTION PARAMETERS”
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


IDENTIFICATION OF A DISTINCT EOSINOPHIL SUBPOPULATION IN INDUCED SPUTUM FROM ATOPIC ASTHMATICS
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018